Brian Druker (English Wikipedia)

Druker, B. J.; Tamura, S.; Buchdunger, E.; Ohno, S.; Segal, G. M.; Fanning, S.; Zimmermann, J.; Lydon, N. B. (May 1996). "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells". Nature Medicine. 2 (5): 561–566. doi:10.1038/nm0596-561. ISSN 1078-8956. PMID 8616716. S2CID 36102747.
Druker, B. J.; Talpaz, M.; Resta, D. J.; Peng, B.; Buchdunger, E.; Ford, J. M.; Lydon, N. B.; Kantarjian, H.; Capdeville, R.; Ohno-Jones, S.; Sawyers, C. L. (2001-04-05). "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia". The New England Journal of Medicine. 344 (14): 1031–1037. doi:10.1056/NEJM200104053441401. ISSN 0028-4793. PMID 11287972.
O'Brien, Stephen G.; Guilhot, François; Larson, Richard A.; Gathmann, Insa; Baccarani, Michele; Cervantes, Francisco; Cornelissen, Jan J.; Fischer, Thomas; Hochhaus, Andreas; Hughes, Timothy; Lechner, Klaus; Nielsen, Johan L.; Rousselot, Philippe; Reiffers, Josy; Saglio, Giuseppe (2003-03-13). "Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia". The New England Journal of Medicine. 348 (11): 994–1004. doi:10.1056/NEJMoa022457. ISSN 1533-4406. PMID 12637609.
Druker, Brian J.; Guilhot, François; O'Brien, Stephen G.; Gathmann, Insa; Kantarjian, Hagop; Gattermann, Norbert; Deininger, Michael W.N.; Silver, Richard T.; Goldman, John M.; Stone, Richard M.; Cervantes, Francisco; Hochhaus, Andreas; Powell, Bayard L.; Gabrilove, Janice L.; Rousselot, Philippe (2006-12-07). "Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia". New England Journal of Medicine. 355 (23): 2408–2417. doi:10.1056/NEJMoa062867. ISSN 0028-4793. PMID 17151364.
Printz, Carrie (2017-05-15). "First person: Brian Druker, MD". Cancer. 123 (10): 1683–1684. doi:10.1002/cncr.30753. ISSN 0008-543X. PMID 28475244.

eur.nl

"Honorary Doctorates | Erasmus University Rotterdam". www.eur.nl. Retrieved 2023-10-13.

hematology.org

"William Dameshek Prize Recipients". www.hematology.org. Retrieved 2023-10-13.
"Ernest Beutler Lecture and Prize Recipients". www.hematology.org. Retrieved 2023-10-13.

hmaward.org.ae

"Prof. Brian J Druker - Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences - HMA". www.hmaward.org.ae. Retrieved 2023-10-13.

indianactsi.org

"Knight Cancer Institute at Oregon Health & Science University director named winner of Watanabe Prize, will deliver keynote address at virtual 2020 Indiana CTSI Annual Meeting". Indiana CTSI. Retrieved 2023-10-13.

japanprize.jp

"The Japan Prize Foundation". The Japan Prize Foundation. Retrieved 2023-10-13.

keio.ac.jp

ms-fund.keio.ac.jp

"Keio Medical Science Prize｜KEIO UNIVERSITY MEDICAL SCIENCE FUND". www.ms-fund.keio.ac.jp. Retrieved 2023-10-13.

kgw.com

"OHSU marks 20 years of life-saving cancer drug". kgw.com. May 7, 2021. Retrieved 2023-10-13.

kva.se

"Targeted treatment of cancer receives the Sjöberg Prize". Kungl. Vetenskapsakademien. 2019-02-04. Retrieved 2023-10-13.

laskerfoundation.org

Strauss, Evelyn. "2009 Winners: Lasker~DeBakey Clinical Medical Research Award". Lasker Foundation. Retrieved 2015-12-27.

lls.org

"Bringing Precision Medicine to AML Patients | Leukemia and Lymphoma Society". www.lls.org. Retrieved 2023-10-13.

luaulegendsofsurfing.org

"Rell Sunn 2019 - Druker and Hunter". Luau & Legends of Surfing Invitational. Retrieved 2023-10-13.

nih.gov

pubmed.ncbi.nlm.nih.gov

Druker, B. J.; Tamura, S.; Buchdunger, E.; Ohno, S.; Segal, G. M.; Fanning, S.; Zimmermann, J.; Lydon, N. B. (May 1996). "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells". Nature Medicine. 2 (5): 561–566. doi:10.1038/nm0596-561. ISSN 1078-8956. PMID 8616716. S2CID 36102747.
Druker, B. J.; Talpaz, M.; Resta, D. J.; Peng, B.; Buchdunger, E.; Ford, J. M.; Lydon, N. B.; Kantarjian, H.; Capdeville, R.; Ohno-Jones, S.; Sawyers, C. L. (2001-04-05). "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia". The New England Journal of Medicine. 344 (14): 1031–1037. doi:10.1056/NEJM200104053441401. ISSN 0028-4793. PMID 11287972.
O'Brien, Stephen G.; Guilhot, François; Larson, Richard A.; Gathmann, Insa; Baccarani, Michele; Cervantes, Francisco; Cornelissen, Jan J.; Fischer, Thomas; Hochhaus, Andreas; Hughes, Timothy; Lechner, Klaus; Nielsen, Johan L.; Rousselot, Philippe; Reiffers, Josy; Saglio, Giuseppe (2003-03-13). "Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia". The New England Journal of Medicine. 348 (11): 994–1004. doi:10.1056/NEJMoa022457. ISSN 1533-4406. PMID 12637609.
Druker, Brian J.; Guilhot, François; O'Brien, Stephen G.; Gathmann, Insa; Kantarjian, Hagop; Gattermann, Norbert; Deininger, Michael W.N.; Silver, Richard T.; Goldman, John M.; Stone, Richard M.; Cervantes, Francisco; Hochhaus, Andreas; Powell, Bayard L.; Gabrilove, Janice L.; Rousselot, Philippe (2006-12-07). "Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia". New England Journal of Medicine. 355 (23): 2408–2417. doi:10.1056/NEJMoa062867. ISSN 0028-4793. PMID 17151364.
Printz, Carrie (2017-05-15). "First person: Brian Druker, MD". Cancer. 123 (10): 1683–1684. doi:10.1002/cncr.30753. ISSN 0008-543X. PMID 28475244.

nytimes.com

Dreifus, Claudia (2009-11-02). "Researcher Behind the Drug Gleevec". The New York Times. ISSN 0362-4331. Retrieved 2023-10-13.

ohsu.edu

"Meet Dr. Brian Druker | Knight Cancer Institute | OHSU". www.ohsu.edu. Retrieved 2023-10-13.
"Brian J. Druker M.D. | OHSU People | OHSU". www.ohsu.edu. Retrieved 2023-10-13.

news.ohsu.edu

Gibbs, Amanda. "OHSU Knight Cancer Institute announces leadership transition". OHSU News. Retrieved 2024-09-11.
"OHSU sets fundraising record by meeting $1 billion challenge from Nike co-founder and wife". OHSU News. Retrieved 2023-10-13.

onclive.com

"OncLive Announces 2013 "Giants of Cancer Care"". OncLive. 2013-07-26. Retrieved 2023-10-13.

oregonlive.com

Terry, Lynne (December 20, 2015) [online date December 17]. "OHSU's $1 billion war on cancer". The Oregonian. Portland, Oregon. pp. A1, A12–A13. Retrieved 2015-12-27.
Dworkin, Andy (October 29, 2008). "OHSU Cancer Institute gets $100 million donation". The Oregonian. Portland, Oregon. Retrieved 2015-12-27.
Budnick, Nick (April 25, 2013). "Top Oregon Health & Science University researcher to doctors: Rise up over drug prices". The Oregonian. Portland, Oregon. Retrieved 2015-12-27.

blog.oregonlive.com

Williams, Elisa (February 22, 2011). "OHSU's Druker recognized for pioneering cancer research". OregonLive.com. Retrieved 2015-12-27.

people.com

Charles, Nick (February 19, 2001). "The Miracle Worker: Dr. Brian Druker Fires a Magic Bullet That May Eliminate a Lethal Form of Leukemia". People. Retrieved 2015-12-27.

pitt.edu

dicksonprize.pitt.edu

www.dicksonprize.pitt.edu https://www.dicksonprize.pitt.edu/recipients/2012-druker.php. Retrieved 2023-10-13. {{cite web}}: Missing or empty |title= (help)

princemahidolaward.org

"Professor Brian J. Druker". Prince Mahidol Award Foundation. 2019-11-23. Retrieved 2023-10-13.

robert-koch-stiftung.de

"Robert Koch Award". www.robert-koch-stiftung.de. Retrieved 2023-10-13.

semanticscholar.org

api.semanticscholar.org

Druker, B. J.; Tamura, S.; Buchdunger, E.; Ohno, S.; Segal, G. M.; Fanning, S.; Zimmermann, J.; Lydon, N. B. (May 1996). "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells". Nature Medicine. 2 (5): 561–566. doi:10.1038/nm0596-561. ISSN 1078-8956. PMID 8616716. S2CID 36102747.

stanford.edu

med.stanford.edu

"2023 Drug Discovery Conference". Stanford Cardiovascular Institute (in Samoan). Retrieved 2023-10-13.

tang-prize.org

"Tang Prize | Laureates | Brian J. Druker". www.tang-prize.org. Retrieved 2023-10-13.

taubmaninstitute.org

"Taubman Prize". A. Alfred Taubman Medical Research Institute. Retrieved 2023-10-13.

time.com

content.time.com

"TIME Magazine Cover: Drugs That Fight Cancer - May 28, 2001". TIME.com. Retrieved 2023-10-13.

ucsf.edu

chancellor.ucsf.edu

"UCSF Medal". Office of the Chancellor. Retrieved 1 July 2020.

warrenalpert.org

"Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org. Retrieved 2023-10-13.

worldcat.org

search.worldcat.org

Druker, B. J.; Tamura, S.; Buchdunger, E.; Ohno, S.; Segal, G. M.; Fanning, S.; Zimmermann, J.; Lydon, N. B. (May 1996). "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells". Nature Medicine. 2 (5): 561–566. doi:10.1038/nm0596-561. ISSN 1078-8956. PMID 8616716. S2CID 36102747.
Druker, B. J.; Talpaz, M.; Resta, D. J.; Peng, B.; Buchdunger, E.; Ford, J. M.; Lydon, N. B.; Kantarjian, H.; Capdeville, R.; Ohno-Jones, S.; Sawyers, C. L. (2001-04-05). "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia". The New England Journal of Medicine. 344 (14): 1031–1037. doi:10.1056/NEJM200104053441401. ISSN 0028-4793. PMID 11287972.
O'Brien, Stephen G.; Guilhot, François; Larson, Richard A.; Gathmann, Insa; Baccarani, Michele; Cervantes, Francisco; Cornelissen, Jan J.; Fischer, Thomas; Hochhaus, Andreas; Hughes, Timothy; Lechner, Klaus; Nielsen, Johan L.; Rousselot, Philippe; Reiffers, Josy; Saglio, Giuseppe (2003-03-13). "Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia". The New England Journal of Medicine. 348 (11): 994–1004. doi:10.1056/NEJMoa022457. ISSN 1533-4406. PMID 12637609.
Dreifus, Claudia (2009-11-02). "Researcher Behind the Drug Gleevec". The New York Times. ISSN 0362-4331. Retrieved 2023-10-13.
Druker, Brian J.; Guilhot, François; O'Brien, Stephen G.; Gathmann, Insa; Kantarjian, Hagop; Gattermann, Norbert; Deininger, Michael W.N.; Silver, Richard T.; Goldman, John M.; Stone, Richard M.; Cervantes, Francisco; Hochhaus, Andreas; Powell, Bayard L.; Gabrilove, Janice L.; Rousselot, Philippe (2006-12-07). "Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia". New England Journal of Medicine. 355 (23): 2408–2417. doi:10.1056/NEJMoa062867. ISSN 0028-4793. PMID 17151364.
Printz, Carrie (2017-05-15). "First person: Brian Druker, MD". Cancer. 123 (10): 1683–1684. doi:10.1002/cncr.30753. ISSN 0008-543X. PMID 28475244.

wustl.edu

commencement-archive.wustl.edu

"Brian J. Druker". Commencement Archive 2014-2019. Retrieved 2023-10-13.

news.wustl.edu

"Five to receive honorary degrees at 149th Commencement" (Press release). Washington University in St. Louis. May 6, 2010. Retrieved 2015-12-27.

wweek.com

"How OHSU's Brian Druker Hopes to Cure Cancer". Willamette Week. Portland, Oregon. January 16, 2014. Retrieved 2015-12-27.